Page 9 - 2012 Update: Guidelines for adult urinary incontinence
P. 9

Bettez et al.



       14.  DuBeau CE. Beyond the bladder: management of urinary incontinence in older women. Clin Obstet Gynecol   41.  Ridout AE, Yoong W. Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical
          2007;50:720-34. http://dx.doi.org/10.1097/GRF.0b013e3180d0a4e7  therapy. J Obstet Gynaecol 2010;30:111-4. http://dx.doi.org/10.3109/01443610903428922
       15.  DuBeau CE, Kuchel GA, Johnson T 2nd, et al. Incontinence in the frail elderly: report from the 4th   42.  Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation
          International Consultation on Incontinence. Neurourol Urodyn 2010;29:165-78. http://dx.doi.  versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J
          org/10.1002/nau.20842                                 Urol 2010;183:1438-43. http://dx.doi.org/10.1016/j.juro.2009.12.036
       16.  Goode PS, Burgio KL, Richter HE, et al. Incontinence in older women. Jama 2010;303:2172-81. http://  43.  Occhino JA, Siegel SW. Sacral nerve modulation in overactive bladder. Curr Urol Rep 2010;11:348-52.
          dx.doi.org/10.1001/jama.2010.749                      http://dx.doi.org/10.1007/s11934-010-0132-6
       17.  Resnick NM, Yalla SV. Detrusor hyperactivity with impaired contractile function. An unrecognized but com-  44.  Chapple C. Systematic review of therapy for men with overactive bladder. Can Urol Assoc J 2011;5:S143-5.
          mon cause of incontinence in elderly patients. JAMA 1987;257:3076-81. http://dx.doi.org/10.1001/  http://dx.doi.org/10.5489/cuaj.11186
          jama.1987.03390220074024                           45.  Athanasopoulos A, Chapple C, Fowler C, et al. The role of antimuscarinics in the management of men
       18.  Ghoniem G, Stanford E, Kenton K, et al. Evaluation and outcome measures in the treatment of female   with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update.
          urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and   Eur Urol 2011;60:94-105. http://dx.doi.org/10.1016/j.eururo.2011.03.054
          clinical practice. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:5-33. http://dx.doi.org/10.1007/  46.  Ng CK, Gonzalez RR, Te AE. Refractory overactive bladder in men: update on novel therapies. Curr Urol
          s00192-007-0495-5                                     Rep 2006;7:456-61. http://dx.doi.org/10.1007/s11934-006-0054-5
       19.  Fritel X, Fauconnier A, Bader G, et al. Diagnosis and management of adult female stress urinary incontin-  47.  Herschorn S, Pommerville P, Stothers L, et al. Tolerability of solifenacin and oxybutynin immediate release
          ence: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur   in older (> 65 years) and younger (</= 65 years) patients with overactive bladder: sub - analysis from
          J Obstet Gynecol Reprod Biol 2010;151:14-9. http://dx.doi.org/10.1016/j.ejogrb.2010.02.041  a Canadian, randomized, double-blind study. Curr Med Res Opin 2011;27:375-82. http://dx.doi.org/
       20.  Thuroff JW, Abrams P, Andersson KE, et al. EAU guidelines on urinary incontinence. Eur Urol 2011;59:387-  10.1185/03007995.2010.541433
          400. http://dx.doi.org/10.1016/j.eururo.2010.11.021  48.  Taylor JA 3rd, Kuchel GA. Detrusor underactivity: Clinical features and pathogenesis of an underdiag-
       21.  Holroyd-Leduc JM, Tannenbaum C, Thorpe KE, et al. What type of urinary incontinence does this woman   nosed geriatric condition. J Am Geriatr Soc 2006;54:1920-32. http://dx.doi.org/10.1111/j.1532-
          have? JAMA 2008;299:1446-56. http://dx.doi.org/10.1001/jama.299.12.1446  5415.2006.00917.x
       22.  Amir B, Farrell SA. SOGC Committee opinion on urodynamics testing. J Obstet Gynaecol Can 2008;30:717-27.  49.  Shamliyan TA, Kane RL, Wyman J, et al. Systematic review: randomized, controlled trials of nonsurgical
       23.  Azzouzi AR, Ballereau C, Desgranchamps F, et al. [Management of male urinary incontinence after radical   treatments for urinary incontinence in women. Ann Intern Med 2008;148:459-73.
          prostatectomy (CTMH AFU 2006-1/5): incidence and role of urodynamic assessment and electromyog-  50.  Dumoulin C, Hay-Smith J. Pelvic floor muscle training versus no treatment, or inactive control treatments,
          raphy]. Prog Urol 2008;18:14-8. http://dx.doi.org/10.1016/j.purol.2007.10.009  for urinary incontinence in women. Cochrane Database Syst Rev 2010:CD005654.
       24.  Gibbs CF, Johnson TM 2nd, Ouslander JG. Office management of geriatric urinary incontinence. Am J Med   51.  Nager CW, Richter HE, Nygaard I, et al. Incontinence pessaries: size, POPQ measures, and successful
          2007;120:211-20. http://dx.doi.org/10.1016/j.amjmed.2006.03.044  fitting. Int Urogynecol J Pelvic Floor Dysfunct 2009;20:1023-8. http://dx.doi.org/10.1007/s00192-
       25.  Resnick NM. An 89-year-old woman with urinary incontinence. JAMA 1996;276:1832-40. http://dx.doi.  009-0866-1
          org/10.1001/jama.1996.03540220056031               52.  Richter HE, Burgio KL, Brubaker L, et al. Continence pessary compared with behavioral therapy or combined
       26.  Nygaard I. Clinical practice. Idiopathic urgency urinary incontinence. N Engl J Med 2010;363:1156-62.   therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol 2010;115:609-17. http://
          http://dx.doi.org/10.1056/NEJMcp1003849               dx.doi.org/10.1097/AOG.0b013e3181d055d4
       27.  Smith AL, Wein AJ. Urinary incontinence: pharmacotherapy options. Ann Med 2011;43:461-76. http://  53.  Lapitan MC, Cody JD, Grant A. Open retropubic colposuspension for urinary incontinence in women.
          dx.doi.org/10.3109/07853890.2011.564203               Cochrane Database Syst Rev 2009:CD002912.
       28.  Kay G, Crook T, Rekeda L, et al. Differential effects of the antimuscarinic agents darifenacin and oxy-  54.  Guerrero KL, Emery SJ, Wareham K, et al. A randomised controlled trial comparing TVT, Pelvicol and
          butynin ER on memory in older subjects. Eur Urol 2006;50:317-26. http://dx.doi.org/10.1016/j.  autologous fascial slings for the treatment of stress urinary incontinence in women. BJOG 2010;117:1493-
          eururo.2006.03.057                                    502. http://dx.doi.org/10.1111/j.1471-0528.2010.02696.x
       29.  Cardozo L. Systematic review of overactive bladder therapy in females. Can Urol Assoc J 2011;5:S139-42.   55.  Albo ME, Richter HE, Brubaker L, et al. Burch colposuspension versus fascial sling to reduce urinary
          http://dx.doi.org/10.5489/cuaj.11185                  stress incontinence. N Engl J Med 2007;356:2143-55. http://dx.doi.org/10.1056/NEJMoa070416
       30.  Wagg AS, Cardozo L, Chapple C, et al. Overactive bladder syndrome in older people. BJU Int 2007;99:502-  56.  Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress
          9. http://dx.doi.org/10.1111/j.1464-410X.2006.06677.x  incontinence. N Engl J Med 2010;362:2066-76. http://dx.doi.org/10.1056/NEJMoa0912658
       31.  Tyagi P, Tyagi V, Chancellor M. Mirabegron: a safety review. Expert Opin Drug Saf 2011;10:287-94.   57.  Novara G, Artibani W, Barber MD, et al. Updated systematic review and meta-analysis of the com-
          http://dx.doi.org/10.1517/14740338.2011.542146        parative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment
       32.  Cartwright R, Renganathan A, Cardozo L. Current management of overactive bladder. Curr Opin Obstet   of female stress urinary incontinence. Eur Urol 2010;58:218-38. http://dx.doi.org/10.1016/j.
          Gynecol 2008;20:489-95. http://dx.doi.org/10.1097/GCO.0b013e32830fe38c  eururo.2010.04.022
       33.  Rovner E, Kennelly M, Schulte-Baukloh H, et al. Urodynamic results and clinical outcomes with intradetrusor   58.  Ross S, Robert M, Swaby C, et al. Transobturator tape compared with tension-free vaginal tape for
          injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic   stress incontinence: a randomized controlled trial. Obstet Gynecol 2009;114:1287-94. http://dx.doi.
          overactive bladder. Neurourol Urodyn 2011;30:556-62. http://dx.doi.org/10.1002/nau.21021  org/10.1097/AOG.0b013e3181c2a151
       34.  Smith CP. Botox(R) in urology--will it become standard of care for urge urinary incontinence? J Urol   59.  Dmochowski RR, Blaivas JM, Gormley EA, et al. Update of AUA guideline on the surgical manage-
          2010;184:2235-6. http://dx.doi.org/10.1016/j.juro.2010.09.050  ment of female stress urinary incontinence. J Urol 2010;183:1906-14. http://dx.doi.org/10.1016/j.
       35.  Apostolidis A. Neuromodulation for intractable OAB. Neurourol Urodyn 2011;30:766-70. http://dx.doi.  juro.2010.02.2369
          org/10.1002/nau.21123                              60.  Walsh CA. TVT-Secur mini-sling for stress urinary incontinence: a review of outcomes at 12 months. BJU
       36.  Dmochowski R, Chapple C, Nitti VW, et al. Efficacy and safety of onabotulinumtoxinA for idiopathic over-  Int 2011;108:652-7.
          active bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol 2010;184:2416-  61.  Giri SK, Hickey JP, Sil D, et al. The long-term results of pubovaginal sling surgery using acellular cross-
          22. http://dx.doi.org/10.1016/j.juro.2010.08.021      linked porcine dermis in the treatment of urodynamic stress incontinence. J Urol 2006;175:1788-92;
       37.  Rickey LM, Kenton K. Botulinum toxin: new option for refractory lower urinary tract symptoms in women.   discussion 93.
          Clin Obstet Gynecol 2008;51:176-86. http://dx.doi.org/10.1097/GRF.0b013e3181621fd2  62.  Cerruto MA, Artibani W. Transobturator versus retropubic synthetic slings: comparative efficacy and safety.
       38.  Al-zahrani AA, Elzayat EA, Gajewski JB. Long-term outcome and surgical interventions after sacral neuromo-  Curr Opin Urol 2011;21:275-80. http://dx.doi.org/10.1097/MOU.0b013e3283476edb
          dulation implant for lower urinary tract symptoms: 14-year experience at 1 center. J Urol 2011;185:981-6.   63.  Lapitan MC, Cody JD, Grant A. Open retropubic colposuspension for urinary incontinence in women: a short
          http://dx.doi.org/10.1016/j.juro.2010.10.054          version Cochrane review. Neurourol Urodyn 2009;28:472-80. http://dx.doi.org/10.1002/nau.20780
       39.  Yamanishi T, Kamai T, Yoshida K. Neuromodulation for the treatment of urinary incontinence. Int J Urol   64.  Centemero A, Rigatti L, Giraudo D, et al. Preoperative pelvic floor muscle exercise for early continence
          2008;15:665-72. http://dx.doi.org/10.1111/j.1442-2042.2008.02080.x  after radical prostatectomy: a randomised controlled study. Eur Urol 2010;57:1039-43. http://dx.doi.
       40.  Herbison GP, Arnold EP. Sacral neuromodulation with implanted devices for urinary storage and voiding   org/10.1016/j.eururo.2010.02.028
          dysfunction in adults. Cochrane Database Syst Rev 2009:CD004202.



       362                                        CUAJ • October 2012 • Volume 6, Issue 5
   4   5   6   7   8   9   10